Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-032308

CRISPR Therapeutics AG · CRSP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owners
Period of report
Oct 24, 2016
Accepted (ET)
Oct 26, 2016 · 6:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001674416

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Oct 24, 2016A95,596$14.00A4,104,045ISee Footnote
Common StockF2,F5Oct 24, 2016A602$14.00A24,334ISee Footnote
Common StockF3,F5Oct 24, 2016A60,219$14.00A2,443,803ISee Footnote
Common StockF4,F5Oct 24, 2016A4,583$14.00A185,987ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses